BP Go (BPP-855)— 510(k) K261061

Substantially Equivalent

Wellvii, Inc.

FDA 510(k) clearance K261061 for BP Go (BPP-855), Substantially Equivalent on 2026-08-13. Applicant: Wellvii, Inc.. Device class: 2.

Summary

Wellvii's BP Go, model BPP-855, is filed under product code DXN, non-invasive blood-pressure measurement systems. No other models are listed.

Class II, 21 CFR 870.1130. Cardiovascular is both the classification panel and the review panel, and the submission type is Traditional.

Wellvii filed from Palm Beach Gardens, Florida. FDA found it substantially equivalent 135 calendar days after receipt (March 31 to August 13, 2026).

Clearance details

Applicant
Wellvii, Inc.
Product code
Product code DXN
Device class
Class 2
Regulation
21 CFR 870.1130
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Palm Beach Gardens, FL, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DXN

view all

More clearances from Wellvii, Inc.

view all

Adverse events under product code DXN

product code DXN
Death
3
Injury
169
Malfunction
1,019
Other
2
Total
1,193

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.